Acute coronary syndrome-associated depression: The salience of a sickness response analogy?

Brain, Behavior, and Immunity

Volumn 49, Issue , 2015, Pages 18-24

  Granville Smith, Isabelle ^a   Parker, Gordon ^a   Cvejic, Erin ^a   Vollmer Conna, Uté ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Acute coronary syndrome; Acute sickness response; Cardiovascular disease; Cytokines; Depression; Immune activation; Inflammatory markers; Subtype

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNE RESPONSE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; COMPLICATION; DEPRESSIVE DISORDER; ILLNESS BEHAVIOR; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY;

ACUTE CORONARY SYNDROME; DEPRESSIVE DISORDER; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION; INFLAMMATION MEDIATORS; RISK FACTORS;

EID: 84940612960     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.02.025     Document Type: Article

References (103)

1. Andersson U., Tracey K.J. Reflex principles of immunological homeostasis. Annu. Rev. Immunol. 2012, 30:313-335. 10.1146/annurev-immunol-020711-075015.
2. Barefoot J.C., Helms M.J., Mark D.B., Blumenthal J.A., Califf R.M., Haney T.L., O'Connor C.M., Siegler I.C., Williams R.B. Depression and long-term mortality risk in patients with coronary artery disease. Am. J. Cardiol. 1996, 78:613-617. 10.1016/S0002-9149(96)00380-3.
3. Barefoot J.C., Brummett B.H., Helms M.J., Mark D.B., Siegler I.C., Williams R.B. Depressive symptoms and survival of patients with coronary artery disease. Psychosom. Med. 2000, 62:790-795.
4. Baune B.T., Stuart M., Gilmour A., Wersching H., Heindel W., Arolt V., Berger K. The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl. Psychiatry 2012, 2:e92. 10.1038/tp.2012.18.
5. Bekke-Hansen S., Trockel M., Burg M.M., Taylor C.B. Depressive symptom dimensions and cardiac prognosis following myocardial infarction: results from the ENRICHD clinical trial. Psychol. Med. 2012, 42:51-60. 10.1017/S0033291711001000.
6. Berkman L.F., Blumenthal J., Burg M., Carney R.M., Catellier D., Cowan M.J., Czajkowski S.M., DeBusk R., Hosking J., Jaffee A. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. J. Am. Med. Assoc. 2003, 289:3106-3116. 10.1001/jama.289.23.3106.
7. Berton G., Palmieri R., Cordiano R., Cavuto F., Pianca S., Palatini P. Acute-phase inflammatory markers during myocardial infarction: association with mortality and modes of death after 7 years of follow-up. J. Cardiovasc. Med. 2010, 11:111-117. 10.2459/JCM.0b013e328332e8e0.
8. Biasucci L.M., Liuzzo G., Grillo R.L., Caligiuri G., Rebuzzi A.G., Buffon A., Summaria F., Ginnetti F., Fadda G., Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999, 99:855-860. 10.1161/01.CIR.99.7.855.
9. Blume J., Douglas S.D., Evans D.L. Immune suppression and immune activation in depression. Brain Behav. Immun. 2011, 25:221-229. 10.1016/j.bbi.2010.10.008.
10. Bull S., Huezo-Diaz P., Binder E., Cubells J., Ranjith G., Maddock C., Miyazaki C., Alexander N., Hotopf M., Cleare A. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment. Mol. Psychiatry 2008, 14:1095-1104. 10.1038/mp.2008.48.
11. Bush D.E., Ziegelstein R.C., Tayback M., Richter D., Stevens S., Zahalsky H., Fauerbach J.A. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am. J. Cardiol. 2001, 88:337-341. 10.1016/S0002-9149(01)01675-7.
12. Carney R., Freedland K. Is there a high-risk subtype of depression in patients with coronary heart disease?. Curr. Psychiatry Rep. 2012, 14:1-7. 10.1007/s11920-011-0247-6.
13. Carney R.M., Freedland K.E. Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease?. Psychosom. Med. 2012, 74:33-38. 10.1097/PSY.0b013e3182405ac4.
14. Carney R.M., Rich M.W., Tevelde A., Saini J., Clark K., Jaffe A.S. Major depressive disorder in coronary artery disease. Am. J. Cardiol. 1987, 60:1273-1275. 10.1016/0002-9149(87)90607-2.
15. Carney R.M., Blumenthal J.A., Freedland K.E., Youngblood M., Veith R.C., Burg M.M., Cornell C., Saab P.G., Kaufmann P.G., Czajkowski S.M. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom. Med. 2004, 66:466-474. 10.1097/01.psy.0000133362.75075.a6.
16. Carney R.M., Freedland K.E., Steinmeyer B., Blumenthal J.A., Berkman L.F., Watkins L.L., Czajkowski S.M., Burg M.M., Jaffe A.S. Depression and five year survival following acute myocardial infarction: a prospective study. J. Affect. Disord. 2008, 109:133-138. 10.1016/j.jad.2007.12.005.
17. Carney R.M., Freedland K.E., Steinmeyer B., Blumenthanl J.A., de Jonge P., Davidson K.W., Czajkawski S.M., Jaffe A.S. History of depression and survival after acute myocardial infarction. Psychosom. Med. 2009, 71:253-259. 10.1097/PSY.0b013e31819b69e3.
18. Cirillo P., Cimmino G., D'Aiuto E., Di Palma V., Abbate G., Piscione F., Golino P., De Palma R. Local cytokine production in patients with Acute Coronary Syndromes: a look into the eye of the perfect (cytokine) storm. Int. J. Cardiol. 2014, 176:227-229. 10.1016/j.ijcard.2014.05.035.
19. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behaviour. Brain Behav. Immun. 2007, 21:153-160. 10.1016/j.bbi.2006.09.006.
20. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:45-56. 10.1038/nrn2297.
21. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436. 10.1016/j.psyneuen.2010.09.012.
22. Davidson K.W. Depression and coronary heart disease. ISRN Cardiol. 2012, 2012. (Article ID 743813). 10.5402/2012/743813.
23. Davidson K.W., Burg M.M., Kronish I.M., Shimbo D., Dettenborn L., Mehran R., Vorchheimer D., Clemow L., Schwartz J.E., Lesperance F., Rieckmann N. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch. Gen. Psychiatry 2010, 67:480-488. 10.1001/archgenpsychiatry.2010.36.
24. de Jonge P., Ormel J., van de Brink R.H.S., van Melle J.P., Spijkerman T.A., Kuijper A., van Veldhuisen D.J., van den Berg M., Honig A., Crijns H., Schene A.H. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am. J. Psychiatry 2006, 163:138-144. 10.1176/appi.ajp.163.1.138.
25. de Jonge P., van den Brink R.H.S., Spijkerman T.A., Ormel J. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J. Am. Coll. Cardiol. 2006, 48:2204-2208. 10.1016/j.jacc.2006.06.077.
26. de Jonge P., Honig A., van Melle J., Schene A., Kuyper A., Tulner D., Schins A., Ormel J. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am. J. Psychiatry 2007, 164:1371-1378. 10.1176/appi.ajp.2007.06091492.
27. de Jonge P., Rosmalen J.G.M., Kema I.P., Doornbos B., van Melle J.P., Pouwer F., Kupper N. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature. Neurosci. Biobehav. Rev. 2010, 35:84-90. 10.1016/j.neubiorev.2009.11.025.
28. de Miranda Azevedo R., Roest A., Hoen P., de Jonge P. Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol. Med. 2014, 1-15. 10.1017/S0033291714000063.
29. Delisle V.C., Abbey S.E., Beck A.T., Dobson K.S., Dozois D.J.A., Grace S.L., Stewart D.E., Ziegelstein R.C., Thombs B.D. The influence of somatic symptoms on Beck Depression Inventory scores in hospitalized postmyocardial infarction patients. Can. J. Psychiatry 2012, 57:752-758.
30. Dickens C., McGowan L., Percival C., Tomenson B., Cotter L., Heagerty A., Creed F. Depression is a risk factor for mortality after myocardial infarction: fact or artifact?. J. Am. Coll. Cardiol. 2007, 49:1834-1840. 10.1016/j.jacc.2007.01.075.
31. Dickens C., McGowan L., Percival C., Tomenson B., Cotter L., Heagerty A., Creed F. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom. Med. 2008, 70:450-455. 10.1097/PSY.0b013e31816a74de.
32. Felger J.C., Lotrich F.E. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013, 246:199-229. 10.1016/j.neuroscience.2013.04.060.
33. Frangogiannis N.G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 2014, 11:255-265. 10.1038/nrcardio.2014.28.
34. Frasure-Smith N., Lespérance F. Depression and other psychological risks following myocardial infarction. Arch. Gen. Psychiatry 2003, 60:627-636. 10.1001/archpsyc.60.6.627.
35. Freedland K.E., Carney R.M. Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med. 2013, 11:131-139. 10.1186/1741-7015-11-131.
36. Glassman A.H., Bigger J.T., Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch. Gen. Psychiatry 2009, 66:1022-1029. 10.1001/archgenpsychiatry.2009.121.
37. Goodman J., Shimbo D., Haas D.C., Davidson K.W., Rieckmann N. Incident and recurrent major depressive disorder and coronary artery disease severity in acute coronary syndrome patients. J. Psychiatr. Res. 2008, 42:670-675. 10.1016/j.jpsychires.2007.07.004.
38. Grace S.L., Abbey S.E., Kapral M.K., Fang J., Nolan R.P., Stewart D.E. Effect of depression on five-year mortality after acute coronary syndrome. Am. J. Cardiol. 2005, 96:1179-1185. 10.1016/j.amjcard.2005.06.052.
39. Grebe K.M., Takeda K., Hickman H.D., Bailey A.M., Embry A.C., Bennink J.R., Yewdell J.W. Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J. Immunol. 2010, 184:540-544. 10.4049/jimmunol.0903395.
40. Grewal K., Stewart D.E., Abbey S.E., Leung Y.W., Irvine J., Grace S.L. Timing of depressive symptom onset and in-hospital complications among acute coronary syndrome inpatients. Psychosomatics 2010, 51:283-288. 10.1176/appi.psy.51.4.283.
41. Groenewold N.A., Doornbos B., Zuidersma M., Vogelzangs N., Penninx B.W., Aleman A., de Jonge P. Comparing cognitive and somatic symptoms of depression in myocardial infarction patients and depressed patients in primary and mental health care. PLoS ONE 2013, 8:e53859. 10.1371/journal.pone.0053859.
42. Gunaratne P., Lloyd A.R., Vollmer-Conna U. Mood disturbance after infection. Aust. N. Z. J. Psychiatry 2013, 47:1152-1164. 10.1177/0004867413503718.
43. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137. 10.1016/s0149-7634(88)80004-6.
44. Hartford M., Wiklund O., Mattsson Hultén L., Perers E., Person A., Herlitz J., Hurt-Camejo E., Karlsson T., Caidahl K. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up. Int. J. Cardiol. 2006, 108:55-62. 10.1016/j.ijcard.2005.04.004.
45. He L., Tang X., Ling W., Chen W., Chen Y. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 2010, 96:339-346. 10.1136/hrt.2009.174912.
46. Hoen P.W., Whooley M.A., Martens E.J., Na B., van Melle J.P., de Jonge P. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J. Am. Coll. Cardiol. 2010, 56:838-844. 10.1016/j.jacc.2010.03.080.
47. Huffman J.C., Celano C.M., Januzzi J.L. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndrome. Neuropsychiatr. Dis. Treat. 2010, 6:123-136. 10.2147/NDT.S6880.
48. Kronish I.M., Rieckmann N., Schwartz J.E., Schwartz D.R., Davidson K.W. Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality?. Psychosom. Med. 2009, 71:697-703. 10.1097/PSY.0b013e3181ad2abd.
49. Larsen K.K., Christensen B., Søndergaard J., Vestergaard M. Depressive symptoms and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based longitudinal study examining health behaviors and health care interventions. PLoS ONE 2013, 8:e74393. 10.1371/journal.pone.0074393.
50. Lee K.S., Lennie T.A., Heo S., Moser D.K. Association of physical versus affective depressive symptoms with cardiac event-free survival in patients with heart failure. Psychosom. Med. 2012, 74:452-458. 10.1097/PSY.0b013e31824a0641.
51. Lesperance F., Frasure-Smith N., Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom. Med. 1996, 58:99-110.
52. Lespérance F., Frasure-Smith N., Théroux P., Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry 2004, 161:271-277. 10.1176/appi.ajp.161.2.271.
53. Leung Y.W., Flora D.B., Gravely S., Irvine J., Carney R.M., Grace S.L. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosom. Med. 2012, 74:786-801. 10.1097/PSY.0b013e31826ddbed.
54. Lichtman J.H., Froelicher E.S., Blumenthal J.A., Carney R.M., Doering L.V., Frasure-Smith N., Freedland K.E., Jaffe A.S., Leifheit-Limson E.C., Sheps D.S. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations a scientific statement from the American Heart Association. Circulation 2014, 129:1350-1369. 10.1161/CIR.0000000000000019.
55. Linke S.E., Rutledge T., Johnson B.D., Vaccarino V., Bittner V., Cornell C.E., Eteiba W., Sheps D.S., Krantz D.S., Parashar S. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch. Gen. Psychiatry 2009, 66:499-507. 10.1001/archgenpsychiatry.2009.27.
56. Liu H., Luiten P.G.M., Eisel U.L.M., Dejongste M.J.L., Schoemaker R.G. Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier and its putative therapeutic implications. Neurosci. Biobehav. Rev. 2013, 37:561-572. 10.1016/j.neubiorev.2013.02.004.
57. Lotrich F.E. Major depression during interferon-α treatment: vulnerability and prevention. Dialogues Clin. Neurosci. 2009, 11:417-425.
58. Maier S.F., Watkins L.R. Role of the medial prefrontal cortex in coping and resilience. Brain Res. 2010, 1355:52-60. 10.1016/j.brainres.2010.08.039.
59. Martens E., Hoen P., Mittelhaeuser M., De Jonge P., Denollet J. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol. Med. 2010, 40:807-814. 10.1017/S0033291709990997.
60. Meijer A., Conradi H.J., Bos E.H., Thombs B.D., van Melle J.P., de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen. Hosp. Psychiatry 2011, 33:203-216. 10.1016/j.genhosppsych.2011.02.007.
61. Meurs M., Zuidersma M., Dickens C., De Jonge P. Examining the relation between post myocardial infarction depression and cardiovascular prognosis using a validated prediction model for post myocardial mortality. Int. J. Cardiol. 2013, 167:2533-2538. 10.1016/j.ijcard.2012.06.042.
62. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741. 10.1016/j.biopsych.2008.11.029.
63. Miller A.H., Haroon E., Raison C.L., Felger J.C. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 2013, 30:297-306. 10.1002/da.22084.
64. Nemeroff C.B., Goldschmidt-Clermont P.J. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat. Rev. Cardiol. 2012, 9:526-539. 10.1038/nrcardio.2012.91.
65. Neumeister A., Konstantinidis A., Stastny J., Schwarz M.J., Vitouch O., Willeit M., Praschak-Rieder N., Zach J., de Zwaan M., Bondy B. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch. Gen. Psychiatry 2002, 59:613-620. 10.1001/archpsyc.59.7.613.
66. O'Neil A., Williams E.D., Stevenson C.E., Oldenburg B., Berk M., Sanderson K. Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study. Soc. Psychiatry Psychiatr. Epidemiol. 2012, 47:1145-1151. 10.1007/s00127-011-0421-5.
67. Ormel J., de Jonge P. Unipolar depression and the progression of coronary artery disease: toward an integrative model. Psychother. Psychosom. 2011, 80:264-274. 10.1159/000323165.
68. Parashar S., Rumsfeld J.S., Spertus J.A., Reid K.J., Wenger N.K., Krumholz H.M., Amin A., Weintraub W.S., Lichtman J., Dawood N. Time course of depression and outcome of myocardial infarction. Arch. Intern. Med. 2006, 166:2035-2043. 10.1001/archinte.166.18.2035.
69. Parker G.B., Hilton T.M., Walsh W.F., Owen C.A., Heruc G.A., Olley A., Brotchie H., Hadzi-Pavlovic D. Timing is everything: the onset of depression and acute coronary syndrome outcome. Biol. Psychiatry 2008, 64:660-666. 10.1016/j.biopsych.2008.05.021.
70. Parker G.B., Hyett M., Walsh W.F., Owen C., Brotchie H., Hadzi-Pavlovic D. Specificity of depression following an acute coronary syndrome to an adverse outcome extends over five years. Psychiatry Res. 2011, 185:347-352. 10.1016/j.psychres.2010.07.015.
71. Pasqui A.L., Di Renzo M., Auteri A., Puccetti L. Cytokines in acute coronary syndromes. Int. J. Cardiol. 2005, 105:355-356. 10.1016/j.ijcard.2005.09.001.
72. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Taubert K., Tracy R.P., Vinicor F., Centers for Disease Control and Prevention; American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
73. Pelletier R., Lavoie K.L., Bacon S.L., Thanassoulis G., Khan N.A., Pilote L. Depression and disease severity in patients with premature acute coronary syndrome. Am. J. Med. 2014, 127(87-93):e82. 10.1016/j.amjmed.2013.09.026.
74. Pereira V.H., Cerqueira J.J., Palha J.A., Sousa N. Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int. J. Cardiol. 2013, 166:30-37. 10.1016/j.ijcard.2012.03.165.
75. Piraino B., Vollmer-Conna U., Lloyd A. Genetic associations of fatigue and other symptom domains of the acute sickness response to infection. Brain Behav. Immun. 2012, 26:552-558. 10.1016/j.bbi.2011.12.009.
76. Poole L., Dickens C., Steptoe A. The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J. Psychosom. Res. 2011, 71:61-68. 10.1016/j.jpsychores.2010.12.009.
77. Poon D.C.-H., Ho Y.-S., Chiu K., Chang R.C.-C. Cytokines: how important are they in mediating sickness?. Neurosci. Biobehav. Rev. 2013, 37:1-10. 10.1016/j.neubiorev.2012.11.001.
78. Quilty L.C., Zhang K.A., Bagby R.M. The latent symptom structure of the Beck Depression Inventory-II in outpatients with major depression. Psychol. Assess. 2010, 22:603-608. 10.1037/a0019698.
79. Raison C.L., Miller A.H. Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias. Brain Behav. Immun. 2013, 31:1-8. 10.1016/j.bbi.2013.04.009.
80. Ramamurthy G., Trejo E., Faraone S.V. Depression treatment in patients with coronary artery disease: a systematic review. Primary Care Companion CNS Disord. 2013, 15. (Article ID r01509). 10.4088/PCC.13r01509.
81. Ramasamy I. Biochemical markers in acute coronary syndrome. Clin. Chim. Acta 2011, 412:1279-1296. 10.1016/j.cca.2011.04.003.
82. Roest A.M., Thombs B.D., Grace S.L., Stewart D.E., Abbey S.E., de Jonge P. Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality. J. Affect. Disord. 2011, 131:158-163. 10.1016/j.jad.2010.11.018.
83. Rutledge T., Reis S.E., Olson M.B., Owens J., Kelsey S.F., Pepine C.J., Mankad S., Rogers W.J., Merz C., Sopko G. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch. Gen. Psychiatry 2006, 63:874-880. 10.1001/archpsyc.63.8.874.
84. Schins A., Tulner D., Lousberg R., Kenis G., Delanghe J., Crijns H.J., Grauls G., Stassen F., Maes M., Honig A. Inflammatory markers in depressed post-myocardial infarction patients. J. Psychiatr. Res. 2005, 39:137-144. 10.1016/j.jpsychires.2004.05.009.
85. Shaffer J.A., Whang W., Shimbo D., Burg M., Schwartz J.E., Davidson K.W. Do different depression phenotypes have different risks for recurrent coronary heart disease?. Health Psychol. Rev. 2012, 6:165-179. 10.1080/17437199.2010.527610.
86. Shimbo D., Rieckmann N., Paulino R., Davidson K. Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart 2006, 92:1316-1318. 10.1136/hrt.2005.075861.
87. Smolderen K.G., Spertus J.A., Reid K.J., Buchanan D.M., Vaccarino V., Lichtman J.H., Bekelman D.B., Chan P.S. Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in Acute Myocardial Infarction Patients' Health Status Registry. Biol. Psychiatry 2012, 71:22-29. 10.1016/j.biopsych.2011.07.029.
88. Spijkerman T., de Jonge P., van den Brink R.H.S., Jansen J.H.C., May J.F., Crijns H.J.G.M., Ormel J. Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes. Gen. Hosp. Psychiatry 2005, 27:411-417. 10.1016/j.genhosppsych.2005.05.007.
89. Steptoe A., Wikman A., Molloy G.J., Messerli-Bürgy N., Kaski J.-C. Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease. Brain Behav. Immun. 2013, 31:183-188. 10.1016/j.bbi.2012.09.002.
90. Suleiman M., Aronson D., Reisner S.A., Kapeliovich M.R., Markiewicz W., Levy Y., Hammerman H. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am. J. Med. 2003, 115:695-701. 10.1016/j.amjmed.2003.06.008.
91. Thombs B.D., Ziegelstein R.C., Parakh K., Stewart D.E., Abbey S.E., Grace S.L. Probit structural equation regression model: general depressive symptoms predicted post-myocardial infarction mortality after controlling for somatic symptoms of depression. J. Clin. Epidemiol. 2008, 61:832-839. 10.1016/j.jclinepi.2007.09.008.
92. Thombs B.D., Ziegelstein R.C., Pilote L., Dozois D.J., Beck A.T., Dobson K.S., Fuss S., de Jonge P., Grace S.L., Stewart D.E. Somatic symptom overlap in Beck Depression Inventory-II scores following myocardial infarction. Br. J. Psychiatry 2010, 197:61-66. 10.1192/bjp.bp.109.076596.
93. Tully P.J., Winefield H.R., Baker R.A., Turnbull D.A., de Jonge P. Confirmatory factor analysis of the Beck Depression Inventory-II and the association with cardiac morbidity and mortality after coronary revascularization. J. Health Psychol. 2011, 16:584-595. 10.1177/1359105310383604.
94. van Melle J.P., de Jonge P., Honig A., Schene A.H., Kuyper A., Crijns H., Schins A., Tulner D., van den Berg M., Ormel J. Effects of antidepressant treatment following myocardial infarction. Br. J. Psychiatry 2007, 190:460-466. 10.1192/bjp.bp.106.028647.
95. Vollmer-Conna U. Acute sickness behaviour: an immune system-to-brain communication?. Psychol. Med. 2001, 31:761-767. 10.1017/S0033291701003841.
96. Vollmer-Conna U., Fazou C., Cameron B., Li H., Brennan C., Luck L., Davenport T., Wakefield D., Hickie I., Lloyd A. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol. Med. 2004, 34:1279-1289. 10.1017/S0033291704001953.
97. Vollmer-Conna U., Piraino B., Cameron B., Hickie I., Wakefield D., Lloyd A. Cytokine polymorphisms have a synergistic effect on illness severity after acute infection. Clin. Infect. Dis. 2008, 47:1418-1425. 10.1086/592967.
98. Watkins L.L., Schneiderman N., Blumenthal J.A., Sheps D.S., Catellier D., Taylor C.B., Freedland K.E. Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am. Heart J. 2003, 146:48-54. 10.1016/S0002-8703(03)00083-8.
99. White P.D., Thomas J.M., Kangro H.O., Bruce-Jones W.D.A., Amess J., Crawford D.H., Grover S.A., Clare A.W. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 2001, 358:1946-1954. 10.1016/S0140-6736(01)06961-6.
100. Whooley M.A. Depression and cardiovascular disorders. Annu. Rev. Clin. Psychol. 2013, 9:327-354. 10.1146/annurev-clinpsy-050212-185526.
101. Ziakas A.G., Koskinas K.C., Souliou E., Gavrilidis S., Giannoglou G.D., Gemitzis K., Styliadis I. Serial measurements of acute phase proteins in patients with acute coronary syndrome. Hellenic J Cardiol. 2011, 52:293-298.
102. Zuidersma M., Thombs B.D., de Jonge P. Onset and recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: a systematic review. Psychother. Psychosom. 2011, 80:227-237. 10.1159/000322633.
103. Zuidersma M., Ormel J., Conradi H., de Jonge P. An increase in depressive symptoms after myocardial infarction predicts new cardiac events irrespective of depressive symptoms before myocardial infarction. Psychol. Med. 2012, 42:683-693. 10.1017/S0033291711001784.